Chinese regulators are putting the brakes on a rush of humanoid-robot companies seeking stock-market listings, people familiar with the matter told Reuters, as they scrutinize whether soaring valuations and revenue tied to state-backed projects reflect underlying commercial demand.
The slowdown followed a volatile Shanghai debut last month by Unitree Robotics, a maker of humanoid and quadruped robots, those people said. Unitree’s shares soared more than fivefold at the open before falling about 55% from their peak, Reuters reported — a swing that highlighted how quickly investor enthusiasm can reverse.
Regulators have used informal “window guidance” to hold back some humanoid listings, the sources said. One described humanoid IPOs as effectively frozen for now; another said there is no formal ban and cast the move as a sector-specific slowdown. The China Securities Regulatory Commission did not respond to Reuters’ request for comment. The Information earlier reported that the CSRC had raised the bar for approving humanoid IPOs via informal guidance to some banks and firms.
The caution lands even as mainland Chinese companies’ fundraising rebounds: share sales and convertible offerings raised $148.9 billion so far in 2026, up 59% from a year earlier, with technology accounting for 41% of the total, according to LSEG data cited by Reuters. Ruiying Zhao of S&P Global Market Intelligence said sentiment is shifting from “blanket euphoria to selective rationality,” with closer checks on whether commercial value justifies premiums.